Emergent Biosolutions Inc (EBS)
Free Cash Flow Growth
-47.83%
Quarterly · Period ending:
EBS Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-47.83%period ending
Latest reported-47.83%period ending
EBS Quarterly Free Cash Flow YoY % (1577.64% → -47.83%)
Year-over-year change
High-resolution chart · PNG
EBS free cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Free Cash Flow Growth |
|---|---|
| -47.8261% | |
| -144.5946% | |
| 190.4412% | |
| -103.854% | |
| 141.2587% | |
| 79.8365% | |
| -494.2029% | |
| 212.0253% | |
| 133.8061% | |
| 63.1341% | |
| -56.3291% | |
| 146.5162% | |
| -166.0377% | |
| -186.4748% | |
| -83.2094% | |
| -164.6753% | |
| 50.6722% | |
| -36.2745% | |
| 35.0072% | |
| -164.7059% | |
| -204.2026% | |
| -251.7857% | |
| 143.1395% | |
| 423.3696% | |
| 285.9719% | |
| -59.7122% | |
| 146.0906% | |
| -112.4396% | |
| -337.8456% | |
| 761.5897% | |
| -380.5681% | |
| 613.2215% | |
| -53.0659% | |
| -158.9975% | |
| 327.8471% | |
| 107.7848% | |
| 293.1429% | |
| 9.1211% | |
| -259.857% | |
| -89.0088% | |
| -185.8696% | |
| 126.1237% | |
| -122.6761% | |
| 23.211% | |
| -234.7312% | |
| -121.531% | |
| 3,339.3269% | |
| 85.0507% | |
| -77.2248% | |
| -174.9695% | |
| 101.8948% | |
| 8.0081% | |
| 155.6589% | |
| -89.0459% | |
| -393.6601% | |
| 394.4817% | |
| 168.2765% | |
| 78.6499% | |
| 15.9563% | |
| -125.6804% | |
| -8,013.6126% | |
| -346.4393% | |
| 138.1985% | |
| 73.8112% | |
| -99.5405% | |
| 140.9622% | |
| -159.0742% | |
| 75.0967% | |
| 3,370.5744% | |
| -152.5378% | |
| -122.8219% | |
| 184.4953% | |
| 96.7598% | |
| -601.8192% | |
| 1,577.6398% |